GTIV News Alert Gentiva Health Services (GTIV) 19.07 12/25/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Gentiva Health Services (GTIV) 19.07 $GTIV

The Zacks Analyst Blog Highlights: Skilled Healthcare Group, Universal Electronics, AmREIT, Gentiva Health Services and 1-800-Flowers.com
PR Newswire - Wed Dec 24, 8:39AM CST
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Skilled Healthcare Group, Inc. (NYSE:SKH-Free Report), Universal Electronics Inc. (Nasdaq:UEIC-Free Report), AmREIT, Inc. (NYSE:AMRE-Free Report), Gentiva Health Services Inc. (Nasdaq:GTIV-Free Report) and 1-800-Flowers.com Inc. (Nasdaq:FLWS-Free Report).
UEIC: 63.97 (+0.53), GTIV: 19.07 (unch)

5 Best Performing Russell 2000 Stocks of 2014 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 23, 1:14PM CST
The Russell 2000 Index has lagged all the major benchmarks for most part of this year but has managed to post modest year-to-date gains, thanks to the favorable economic environment prevailing on the domestic front.
AMRE: 26.53 (-0.01), UEIC: 63.97 (+0.53), SKH: 8.73 (-0.02), FLWS: 8.07 (+0.18), GTIV: 19.07 (unch)

Kindred Healthcare Closes $1.35 Billion Senior Unsecured Notes Offering; Announces February 2 Target Closing Date for Merger with Gentiva Now That All Financing is Complete
Business Wire - Thu Dec 18, 3:30PM CST
Kindred Healthcare, Inc. ("Kindred" or the "Company" (NYSE:KND) today announced that it has closed its previously announced offering of $1.35 billion aggregate principal amount of senior unsecured notes. The $1.35 billion of notes were issued in two tranches of $750 million of 8.00% Senior Notes due 2020 at an issue price of 100% and $600 million of 8.75% Senior Notes due 2023 at an issue price of 100% (collectively, the "Notes" .
KND: 18.21 (+0.11), GTIV: 19.07 (unch)

Gentiva Health Services posts 3Q profit
Automated Insights - Wed Dec 17, 4:01AM CST
ATLANTA (AP) _ Gentiva Health Services Inc. (GTIV) on Wednesday reported third-quarter profit of $8 million.
GTIV: 19.07 (unch)

DaVita to Merge Business Units, Advance Clinical Research - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 16, 12:40PM CST
DaVita HealthCare Partners Inc.'s (DVA) business units ??? DaVita Clinical Research (DCR) and HealthCare Partners Clinical Research ??? are set to merge.
AFAM: 29.53 (-0.06), DVA: 76.06 (+0.07), AMED: 28.97 (-0.08), GTIV: 19.07 (unch)

United States Home Health and Hospice Care Industry Analytics 2014-2021 - Market to reach $141 Billion by 2021
M2 - Mon Dec 15, 8:50AM CST
Research and Markets (http://www.researchandmarkets.com/research/8wh7p6/home_health_and) has announced the addition of Plunkett Research Ltd's new report "Home Health and Hospice Care Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 621600" to their offering. Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research. Key Findings: - Home Health and Hospice Care Industry (U.S.) to reach $131.3 billion by 2021. - Home Health and Hospice Care Industry, including Average EBITDA, Operating Ratios and Sales per Employee. Core Benefits to Customer: 1. Comprehensive overview of an industry's financial results, ratios, vital statistics and metrics in one package 2. Complete benchmarking of the industry and its top companies 3. Deep industry and company financials This Report Features: 1. Historical data 2. Revenue forecasts, growth rates and CAGR 3. Operating ratios 4. Complete data for benchmarking a company to its industry and to specific leading companies 5. Benchmarking this industry to all U.S. industries 6. Deep profiles and financial histories/operating ratios for up to ten top U.S.-based companies Designed to benefit: - Analysis and Financial Modeling - Investment Professionals - Lenders - M&A Advisors - Appraisers - Consultants Key Data: Industry Summary - Revenues historical through 2013 - Revenues projected through 2021 - Employee Count 2007-2013 - Annual Growth Rate 2013 - CAGR 2006 through 2013 - CAGR 2014 through 2021 - Top U.S. Companies Employment and Establishments - Number of Firms 2007-2013 - Number of Establishments 2007-2013 - Employees, 2007-2013 - Average Annual Sales per Firm & per Establishment 2007-2013 - Sales per Employee Average Annual Operating Ratios - Revenue Compared to All Industries - Expenses Compared to All Industries - Profits & Income Taxes Compared to All Industries Benchmarks This Industry Compared to All Industries - Comparison of Revenues, Profits and Taxes to All Industries Industry Results, Publicly-Held Companies (U.S.), Average for all Companies - Industry Income Statement, Balance Sheet, Cash Flow Statement, 2008-2013 Top Companies Profiled & Ranked In-Depth Profiles, Financial Reports, Ranks & Executive Lists for Top U.S.-Based Corporations Top Companies Ranked - Market Capitalization - Employees - Revenue - Net Income - 3-Year Revenue Growth - 3-Year Income Growth - Return on Assets - Return on Equity - Return on Invested Capital List of Leading (Public and Private) Companies - Addus Homecare Corp - Almost Family Inc - Amedisys Inc - American HomePatient Inc - Apria Healthcare Group Inc - BioScrip Inc - Chemed Corporation - Gentiva Health Services Inc - LHC Group Inc - Lincare Holdings Inc For more information visit http://www.researchandmarkets.com/research/8w...health_and Source: Plunkett Research Ltd
CHE: 106.16 (+0.13), AFAM: 29.53 (-0.06), LHCG: 30.33 (-0.21), BIOS: 6.37 (unch), AMED: 28.97 (-0.08), GTIV: 19.07 (unch)

Kindred Healthcare Expands Borrowing Capacity under Its Revolving Credit Agreement by $150 Million
Business Wire - Mon Dec 15, 6:00AM CST
Kindred Healthcare, Inc. ("Kindred" or the "Company" (NYSE:KND) today announced that it has entered into an incremental joinder to increase the available credit capacity from $750 million to $900 million under its senior secured asset-based revolving credit facility (the "ABL Facility" .
KND: 18.21 (+0.11), GTIV: 19.07 (unch)

Kindred Healthcare Announces Pricing of $1.35 Billion of Senior Unsecured Notes
Business Wire - Thu Dec 11, 4:32PM CST
Kindred Healthcare, Inc. ("Kindred" or the "Company" (NYSE:KND) today announced that it has priced its previously announced offering of $1.35 billion aggregate principal amount of senior unsecured notes. The $1.35 billion of notes will be issued in two tranches of $750 million of 8.00% Senior Notes due 2020 at an issue price of 100% and $600 million of 8.75% Senior Notes due 2023 at an issue price of 100% (collectively, the "Notes" . The sale of the Notes is expected to be completed on December 18, 2014, subject to customary closing conditions.
KND: 18.21 (+0.11), GTIV: 19.07 (unch)

Humana Inks Deal with Metro Health to Enhance Healthcare - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 10, 4:56PM CST
Humana Inc. (HUM) recently entered into an agreement with Metro Health, an integrated hospital and physician network operating in West Michigan.
CNC: 105.96 (+1.03), AFAM: 29.53 (-0.06), GTIV: 19.07 (unch), HUM: 144.38 (-0.31)

The Right Time to Invest in Amedisys (AMED)? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 09, 4:15PM CST
On Dec 8, 2014, we issued an updated research report on Amedisys Inc. (AMED).
CHE: 106.16 (+0.13), AFAM: 29.53 (-0.06), AMED: 28.97 (-0.08), GTIV: 19.07 (unch)

3 Cheap Dividend Stocks That Could Be Top Stocks in 2015
Todd Campbell, The Motley Fool - Motley Fool - Mon Dec 08, 7:15AM CST
Source: Flickr user  Simon Cunningham . It's been proven time and time again that long-term investing out performs short-term trading. It's also been shown that investing in dividend paying stocks leads to better returns than investing in...
KND: 18.21 (+0.11), MYL: 56.97 (+0.39), TEVA: 57.09 (+0.33), GTIV: 19.07 (unch), OMI: 35.31 (+0.01)

Kindred Healthcare Announces Proposed Offering of $1.35 Billion of Senior Unsecured Notes
Business Wire - Mon Dec 08, 6:32AM CST
Kindred Healthcare, Inc. ("Kindred" or the "Company" (NYSE:KND) today announced that it proposes to offer, subject to market and other conditions, $1.35 billion of senior unsecured notes (the "Notes" to qualified institutional buyers in accordance with Rule 144A under the Securities Act of 1933, as amended (the "Securities Act" , and to certain non-United States persons in offshore transactions in accordance with Regulation S under the Securities Act. The actual terms of the Notes, including interest rate, principal amount and maturity, will be determined at the time of pricing. The Notes are expected initially to be issued by Kindred's subsidiary, Kindred Escrow Corp. II.
KND: 18.21 (+0.11), GTIV: 19.07 (unch)

Why 2014 Is the Biggest Year for Deals Since the Financial Crisis
at The Street - Mon Dec 08, 5:10AM CST
U.S. M&A jumped 38% in the first 10 months of the year from a year earlier, and is likely to mark the strongest year for deals since 2008 financial crisis.
ACT: 254.20 (-1.68), TERP: 29.40 (-0.09), MDT: 74.08 (+0.31), CHTR: 167.46 (-0.31), TWX: 85.58 (-0.20), AGN: 210.12 (+0.95), T: 33.96 (-0.07), FOX: 37.33 (+0.02), EBAY: 57.10 (-0.12), DTV: 86.82 (-0.05), JDSU: 14.01 (+0.13), GTIV: 19.07 (unch), WAG: 76.67 (+0.16), BHI: 56.34 (-0.10), KND: 18.21 (+0.11), ABT: 45.70 (-0.02), EXC: 37.85 (+0.61), COV: 103.35 (+0.57), HAL: 39.70 (-0.18), TSN: 40.33 (-0.90), HPQ: 40.54 (+0.18), SYMC: 26.58 (+0.13), ZTS: 43.84 (+0.87), POM: 26.89 (+0.16), SUNE: 19.50 (+0.01), GIS: 54.31 (-0.10), PETM: 81.16 (+0.03)

Health Net's Liquidity Looks Good, Customer Attrition a Drag - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 03, 5:20PM CST
On Dec 2, 2014, we issued an updated research report on Health Net, Inc. (HNT).
CNC: 105.96 (+1.03), UNH: 102.68 (-0.17), GTIV: 19.07 (unch), HNT: 53.73 (+0.02)

Humana's (HUM) Back-to-Back ACO Deals to Draw Investors - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 03, 12:20PM CST
The back-to-back signing of Accountable Care agreements within just the first two days of Dec 2014 definitely positions Humana Inc. (HUM) favorably with investors and potential members.
CNC: 105.96 (+1.03), UNH: 102.68 (-0.17), GTIV: 19.07 (unch), HUM: 144.38 (-0.31)

Humana Signs Accountable Care Deal with Banner Network - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 02, 11:30AM CST
Humana Inc. (HUM) recently entered into a new Accountable Care agreement with Banner Network Colorado (BNC), an integrated provider delivery network in North Colorado.
CNC: 105.96 (+1.03), GTIV: 19.07 (unch), WLP: 128.71 (+0.94), HUM: 144.38 (-0.31)

Global Home Healthcare Market - 2014-2020 Industry Analysis
M2 - Tue Dec 02, 9:48AM CST
Research and Markets (http://www.researchandmarkets.com/research/k4nfpx/global_home) has announced the addition of the "Global Home Healthcare Market - Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020" report to their offering. The global home healthcare market, by services has been segmented into rehabilitation services, respiratory therapy services, telehealth and telemedicine services, infusion therapy services and unskilled home healthcare services. The market size and forecast in terms of USD million for each service has been provided for the period 2012 to 2020, considering 2013 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2014 to 2020 for each segment. Geographically, the global home healthcare systems market has been segmented into four major regions: North America, Europe, Asia Pacific and Rest of the World (RoW). The market size and forecast for each geography has been estimated for the period 2012 to 2020 in terms of revenue (USD million), considering 2013 as the base year. The report also provides the compounded annual growth rate (CAGR %) during the forecast period from 2014 to 2020 for all the geographies mentioned above. The market overview section of the report discusses the market dynamics with respect to the market drivers, restraints and opportunities. This section also covers market attractiveness analysis, event impact and value chain analysis of the global home healthcare market. Market share (%) of major players operating in the market has also been provided for the year 2013, followed by a list of recommendations for existing and new players to enter and enhance market share. The report concludes with company profiles of key players operating in various segments of the market. Each company profile includes business overview, financial overview, product portfolio, business strategies and recent developments of the respective company. Scope of the Report Global Home Healthcare Market, by Device Types Diagnostics and Monitoring Home Devices - Blood Glucose Monitors - Blood Pressure Monitors - Heart Rate Monitors - Temperature Monitors - Sleep Apnea Monitors - Coagulation Monitors - Pregnancy Test Kits - Pulse Oximeters - Pedometers Therapeutics Home Healthcare Devices - Insulin Delivery Devices - Nebulizers - Ventilator and CPAP Devices - IV Equipments - Dialysis Equipment Home Mobility Assist Devices - Wheelchairs - Cranes and Crutches - Other Home Mobility Assist Devices Medical Supplies Global Home Healthcare Market, by Services - Rehabilitation Services - Telehealth and Telemedicine Services - Infusion Therapy Services - Respiratory Therapy Services - Unskilled Home Healthcare Services Companies Mentioned - 3M Healthcare - Abbott Laboratories - Bayer AG - Becton, Dickinson and Company - Cardinal Health - F. Hoffmann-La Roche Ltd. - GE Healthcare - Gentiva Health Services, Inc. - Invacare Corporation - Johnson & Johnson Services, Inc. - Medtronic, Inc. - Omron Healthcare, Inc. - Philips Healthcare - Praxair Technologies, Inc. - ResMed, Inc. - Sunrise Medical LLC - Teleflex Incorporated - The Linde Group For more information visit http://www.researchandmarkets.com/research/k4...lobal_home
JNJ: 104.59 (+0.31), ABT: 45.70 (-0.02), MDT: 74.08 (+0.31), IVC: 16.80 (+0.20), RMD: 57.39 (+0.40), TFX: 116.82 (+0.28), GTIV: 19.07 (unch)

Gentiva's (GTIV) Inorganic Growth Strategies Look Impressive - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Dec 01, 2:10PM CST
On Nov 27, 2014, we issued an updated research report on Gentiva Health Services Inc. (GTIV).
KND: 18.21 (+0.11), AMSG: 54.43 (+0.41), AFAM: 29.53 (-0.06), GTIV: 19.07 (unch)

Latin America Home Healthcare Market - Industry Analysis 2014 - 2020
M2 - Thu Nov 27, 3:26AM CST
Research and Markets (http://www.researchandmarkets.com/research/fgc9q4/latin_america) has announced the addition of the "Latin America Home Healthcare Market - Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020" report to their offering. The Latin America home healthcare market is estimated to be USD 9.7 billion in 2013 and is expected to reach USD 17.55 billion by 2020, growing at a CAGR of 8.7% from 2014 to 2020 Home healthcare devices and services help the patients to be self-sufficient towards their health. This is been increasingly accepted by the patient population owing to its cost effective nature, less number of visits to hospital and patient comfort. The Latin America home healthcare market has witnessed significant growth in the past due to factors such as increasing number of patients diagnosed with chronic diseases like diabetes, cardiac disorders, respiratory diseases and others. At the same time, economic instability and reimbursement issues related to home healthcare services are the factors restraining the market growth during the forecast period from 2014 to 2020. This report provides an in-depth and comprehensive analysis of the Latin America home healthcare market on the basis of device types, services and the major Latin American geographies. In device types segment, the report covers different types of diagnostic and monitoring devices, therapeutic devices, medical supplies and home mobility assist devices that are used by the patients. Diagnostics and monitoring devices segment includes devices such as blood glucose monitors, blood pressure monitors, sleep apnea monitors, pregnancy test kits, pulse oximeters, heart rate monitors, temperature monitors, pedometers and coagulation monitors. Therapeutic devices segment comprises insulin delivery devices, nebulizers, ventilators and CPAP devices, IV equipment and dialysis equipment. The home mobility assist devices segment is further categorized as wheelchairs, cranes and crutches and other mobility assist devices and medical supplies segment includes feeding tubes and syringes. The market size and forecast for each device type has been provided for the period 2012 to 2020, considering 2013 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2014 to 2020 for each segment. The Latin American home healthcare market is segmented as follows: Latin American Home Healthcare Market, by Device Types - Diagnostics and Monitoring Home Devices - Blood Glucose Monitors - Blood Pressure Monitors - Heart Rate Monitors - Temperature Monitors - Sleep Apnea Monitors - Coagulation Monitors - Pregnancy Test Kits - Pulse Oximeters - Pedometers - Therapeutics Home Healthcare Devices - Insulin Delivery Devices - Nebulizers - Ventilator and CPAP Devices - IV Equipments - Dialysis Equipment - Home Mobility Assist Devices - Wheelchairs - Cranes and Crutches - Other Home Mobility Assist Devices - Medical Supplies Latin American Home Healthcare Market, by Services - Rehabilitation Services - Telehealth and Telemedicine Services - Infusion Therapy Services - Respiratory Therapy Services - Unskilled Home Healthcare Services Companies Mentioned - 3M Healthcare - Abbott Laboratories - Bayer AG - Cardinal Health - F. Hoffmann-La Roche Ltd. - GE Healthcare - Gentiva Health Services, Inc. - Invacare Corporation - Johnson & Johnson Services, Inc. - Medtronic, Inc. - Omron Healthcare, Inc. - Philips Healthcare - Praxair Technologies, Inc. - ResMed, Inc. - Teleflex Incorporated - The Linde Group For more information visit http://www.researchandmarkets.com/research/fg...in_america
JNJ: 104.59 (+0.31), ABT: 45.70 (-0.02), MDT: 74.08 (+0.31), IVC: 16.80 (+0.20), RMD: 57.39 (+0.40), TFX: 116.82 (+0.28), GTIV: 19.07 (unch)

Kindred Healthcare Closes Public Offerings of Common Stock and Tangible Equity Units
Business Wire - Tue Nov 25, 4:00PM CST
Kindred Healthcare, Inc. ("Kindred" or "the Company" (NYSE:KND) today announced that it has closed the concurrent underwritten public offerings of 5,000,000 shares of Kindred's common stock and 150,000 tangible equity units. The Company granted the underwriters a 30-day over-allotment option to purchase up to an additional 750,000 shares of Kindred's common stock and a 13-day over-allotment option to purchase up to an additional 22,500 tangible equity units. Citigroup Global Markets Inc., J.P. Morgan Securities LLC, Guggenheim Securities, LLC and Morgan Stanley & Co. LLC acted as book-running managers for the concurrent offerings.
KND: 18.21 (+0.11), JPM: 62.48 (unch), GTIV: 19.07 (unch)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Charter Investigation Puts ACP Exit Claims Under Lens

Updated Category News Views 83

Charter’s ACP hangover has grown from an operating headache into a governance question. Kahn Swick & Foti said on November 20, 2026, that it has begun investigating whether Charter Communications officers or directors breached fiduciary duties or otherwise broke state or federal law. That is not a finding of wrongdoing, and investors ought to keep that distinction...

Continue Reading
Mason Adds Nonprofit Expertise to Institutional Bench

Updated Category News Views 110

Endowment committees rarely need more noise; they need somebody who has actually sat through the uncomfortable votes. Mason Investment Advisory Services has hired Rebecca “Becky” Farnsworth, CFA, as a senior investment consultant, and this looks like a practical addition rather than the usual chest-thumping personnel announcement. Her stated focus will be...

Continue Reading
California Stone Ban Puts a Hidden Worker Toll in View

Updated Category News Views 42

Countertops are supposed to finish a kitchen, not quietly wreck the lungs of the people cutting them. Yet California's move toward prohibiting the fabrication and installation of artificial stone containing more than 1% crystalline silica puts an ugly, long-running occupational-health problem in plain sight. This is not a story that calls for chest-thumping market talk....

Continue Reading
Tessera Delisting Leaves HLSQ in a Tougher Market Ahead

Updated Category News Views 116

November delivered a nasty little truth serum for Tessera Defense and Homeland Security: exchange status is not a cosmetic detail when the stock’s selling price has collapsed. On November 10, NYSE Regulation suspended trading in the company’s common shares on NYSE American and began delisting proceedings. By November 17, Tessera had a chance to request review by the...

Continue Reading
Jalisco’s Culinary Push Puts Tourism Strategy in Focus

Updated Category News Views 50

A destination sells itself twice: first with a memorable meal, then with a reason to come back. Jalisco’s stated effort to connect the world’s cuisines through The 50 Best Gastronomic Experiences belongs in that second category. It is not merely restaurant chatter. It reads as part of a broader attempt to make the state’s tourism offering feel deeper, more varied...

Continue Reading
Epic Blue Puts $50,000 of Marketing Work to Use Locally

Updated Category News Views 84

A $50,000 pile of donated know-how can look soft on a spreadsheet, until you remember how often a small nonprofit or early-stage outfit gets ignored because it cannot afford someone to sharpen its message. Epic Blue Marketing, a women-owned firm based in Jackson, Michigan, says it provided that amount in donated and reduced-rate marketing, communications and public...

Continue Reading
Veterinary Biologics Growth Has a Valuable Catch Ahead

Updated Category News Views 124

Pet allergies and livestock disease are hardly glamorous, yet they are becoming a durable spending lane. The veterinary biologics market is projected to rise from $2.85 billion in 2026 to $3.69 billion by 2031, a 5.3% compound annual growth rate. That is not the kind of growth figure that makes anyone pound the table, and frankly it should not. It is the sort that can...

Continue Reading
California Rideshare Data Exposes an Insurance Gap

Updated Category News Views 46

Three California counties carried an outsized share of rideshare traffic, and the insurance fine print is where this story gets uncomfortable. A review by Mendez & Sanchez says Los Angeles, San Francisco, and San Diego counties accounted for nearly two-thirds of statewide rideshare trips between September 2019 and August 2020. That is an old snapshot, sure, but it points...

Continue Reading
Delayed Remodels Can Quietly Drain Your Home's Value

Updated Category News Views 51

A pinhole leak has a nasty talent for becoming a demolition budget. That is the plain lesson in Jason Marks' discussion of delayed remodeling for homeowners in Kernersville, North Carolina. People tend to see a worn bathroom, tired kitchen, or drafty window and think, “Not pretty, but it can wait.” Sometimes it can. Sometimes that little delay lets water, rot,...

Continue Reading
BON’s Oat Lab Bet Puts Scale and Standards in Focus

Updated Category News Views 32

Oats Meet the Industrialization Problem Oats rarely make a small-cap story more interesting, yet this one has a real business nerve running through it. Bon Natural Life has teamed with China Oat Group to establish a joint laboratory aimed at biomanufacturing high-value, oat-derived natural ingredients. The headline is not simply another research collaboration. The stated...

Continue Reading

Top 5 Most Recently Viewed Articles

Disney Cruise Line Celebrates Employees as Godparents of Treasure

Updated Category News Views 97

Disney Cruise Line Celebrates Employees in Honor of Disney Treasure Disney Cruise Line is redefining maritime traditions in a beautiful manner by honoring its dedicated employees worldwide. The company’s latest announcement revealed that the honorific role of "godparent" for the new ship, the Disney Treasure, will be shared among its tremendous cast, crew, Imagineers,...

Continue Reading
Regional Management Corp. to Share Q3 2024 Financial Insights

Updated Category News Views 79

Regional Management Corp. to Announce Q3 Results Greenville, S.C. – Regional Management Corp. (NYSE: RM), a prominent player in the consumer finance sector, is set to share its financial results for the third quarter of 2024. Conference Call Details and Replay The company will report its quarterly results after market close, providing investors and stakeholders with...

Continue Reading
Suvoda Recognized as a Leader in Clinical Trial Technology

Updated Category News Views 147

Suvoda Acknowledged as a Leader in RTSM Technology Suvoda, a cutting-edge clinical trial technology company, recently shared exciting news about their IRT (Interactive Response Technology) software, which has been designated as a Leader in the prominent Everest Group's PEAK Matrix assessment for RTSM (Randomization and Trial Supply Management) technology. This recognition...

Continue Reading
Cereno Scientific Expands CS014 Focus to Combat PH-ILD

Updated Category News Views 131

Cereno Scientific Expands CS014 Focus to Combat PH-ILD Cereno Scientific, a pioneering biotech company, has made a significant announcement regarding the development focus of its HDAC inhibitor CS014. This innovative treatment is now targeting pulmonary hypertension associated with interstitial lung disease (PH-ILD), an area marked by a high level of unmet medical need....

Continue Reading
Dysmenorrhea Treatment Market Growth Insights for 2032

Updated Category News Views 188

Global Dysmenorrhea Treatment Market Insights Dysmenorrhea, commonly referred to as menstrual cramps, affects many women globally, causing significant discomfort during their menstrual cycles. Recent trends indicate that as awareness of this condition grows, so does the demand for effective treatments. The global dysmenorrhea treatment market is projected to surpass USD 8...

Continue Reading